OpenAlex
PricingAboutJobs
Log inGet started
Author

Xiuyi Yu

Observed names: X. Yu, Yu, Xiuyi
Institutions: First Affiliated Hospital of Xiamen University, Guangzhou Medical University Cancer Hospital, Guangzhou Medical University
Observed institutions: First Affiliated Hospital of Xiamen University, Guangzhou Medical University Cancer Hospital, Guangzhou Medical University
ORCID: 0009-0007-3472-6263
Observed ORCID: 0009-0007-3472-6263
OpenAlex ID: A5022219374
Translation regulatory long non‐coding RNA 1 negatively regulates cell radiosensitivity via the miR‐22‐3p/SP1 axis in non‐small cell lung cancer
2024 · Ming Zhong, Zheng Fang, et al. · The Clinical Respiratory Journal · 5
PDF
1884P Surufatinib-based late-line therapy outcomes in recurrent metastatic NSCLC: Monotherapy and vinorelbine combination regimens
2025 · Y. Zheng, F. Niu, et al. · Annals of Oncology
Envafolimab combined with albumin-bound paclitaxel and cisplatin in the neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma: A prospective, single-arm, multicenter phase II study.
2025 · Zhinuan Hong, Shijie Huang, et al. · Journal of Clinical Oncology
PDF
1039P Efficacy and safety of surufatinib (HMPL-012) as a third-line or further treatment for advanced non-small cell lung cancer (NSCLC)
2022 · Y. Zheng, F. Niu, et al. · Annals of Oncology
Works count: 6
Citation count: 5
H-index: 1
I10-index:
Year
Topic
Type
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms